Brief: Xintela's Stem Cells Show Promising Results In Preclinical ARDS Study

Xintela AB

26/10/2020 07:57

Oct 26 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA'S STEM CELLS SHOW PROMISING RESULTS IN PRECLINICAL
ARDS
STUDY
    * ARDS IS A LIFE-THREATENING LUNG COMPLICATION THAT MAY
AFFECT
SEVERELY ILL COVID-19 PATIENTS.

Source text for Eikon:  ID:nBQN4Hy7rV 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))